China Biohacking Market Size & Outlook, 2024-2030
China biohacking market, 2018-2030 (US$M)
Related Markets
China biohacking market highlights
- The China biohacking market generated a revenue of USD 1,126.6 million in 2024 and is expected to reach USD 3,433.6 million by 2030.
- The China market is expected to grow at a CAGR of 20.9% from 2025 to 2030.
- In terms of segment, wearables was the largest revenue generating product in 2024.
- Smart Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
Biohacking market data book summary
| Market revenue in 2024 | USD 1,126.6 million |
| Market revenue in 2030 | USD 3,433.6 million |
| Growth rate | 20.9% (CAGR from 2025 to 2030) |
| Largest segment | Wearables |
| Fastest growing segment | Smart Drugs |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Wearables, Implants (Chips), Gene Modification Kits, Smart Drugs, Supplements, Mobile Apps |
| Key market players worldwide | Apple Inc, Fitbit, Harvey Norman Holdings Ltd, The ODIN, Thync, Moodmetric, Thriveport, TrackMyStack, OsteoStrong San Jose |
Other key industry trends
- In terms of revenue, China accounted for 4.5% of the global biohacking market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan biohacking market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,623.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biohacking Market Scope
Biohacking Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China biohacking market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biohacking market will help companies and investors design strategic landscapes.
Wearables was the largest segment with a revenue share of 35.18% in 2024. Horizon Databook has segmented the China biohacking market based on wearables, implants (chips), gene modification kits, smart drugs, supplements, mobile apps covering the revenue growth of each sub-segment from 2018 to 2030.
China’s biohacking market is growing due to strong government support for biotech innovation, increasing consumer demand for longevity solutions, and advancements in genetic research. The country’s leadership in AI-driven health monitoring and precision medicine is accelerating the adoption of biohacking technologies. Companies and research institutes are actively exploring applications in gene editing, wearable biosensors, and bioelectronic implants.
Reasons to subscribe to China biohacking market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China biohacking market databook
-
Our clientele includes a mix of biohacking market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China biohacking market , including forecasts for subscribers. This country databook contains high-level insights into China biohacking market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China biohacking market size, by product, 2018-2030 (US$M)
China Biohacking Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
